Here is what the company reported: Participants in SURMOUNT-3, after 12 weeks of intensive lifestyle intervention, achieved an additional 21.1% mean weight loss with tirzepatide for a total mean weight loss of 26.6% from study entry over 84 weeks Participants in SURMOUNT-4 achieved 21.1% weight loss during a 36-week tirzepatide lead-in period and an additional 6.7% weight loss during a 52-week continued treatment period, for a total mean weight loss of 26.0% over 88 weeks. How Does Zepbound Compare to Wegovy
The choice of treatment depends on individual circumstances, including the severity of diabetes, previous treatment response, and personal preferences
About this Treatment Our team of medical providers at MinuteMD will review your medical information and determine which course of treatment is appropriate for you
While the exact timing may vary from person to person, it's not uncommon to hit a plateau several months into your treatment (2,3)
31,32 Patients with obesity have a higher quantity of epicardial adipose tissue
Pure health peptides ReSeARCH PePTIDeS YOU CAN TRUST